Advanced Circulatory Systems, Inc.

Rebroadcast Nov 12, 09
Webinar

Improving Resuscitation with a Systems Based Approach:
An Update on Six Clinical Investigations

ResQ Trial

This page contains a link to educational information for the ResQ Trial, which is a U.S. FDA-approved pre-market clinical study of the combination of two medical devices -- a version of the ResQPOD Impedance Threshold Device manufactured specifically for the ResQ Trial and a ResQPump Active Compression Decompression CPR Device.

The device combination referenced in these educational materials is not available for sale in the United States.

These educational materials are not intended to imply outcomes-based claims for the investigational device combination not yet approved by the U.S. FDA.
By clicking this link I agree that I am viewing these materials for the purposes of education and training for the ResQ Trial.

I Accept:

The generally cleared indication for the ResQPOD is a temporary increase in blood circulation during emergency care, hospital, clinic and home use.
Click here to review the Instructions for Use. Studies are ongoing in the United States to evaluate the long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis and severe blood loss.

For more information on completed clinical studies click here. The references on this website are not intended to imply specific outcome-based claims not yet cleared by the US Food and Drug Administration.